Compare Cigna Corp (CI) vs Verisign, Inc. (VRSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Verisign, Inc. — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Verisign, Inc. trades at $288.99 (market cap $26.52B). The key difference: Cigna Corp is far larger — about 2.8× Verisign, Inc.'s market cap, and Cigna Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| CI | VRSN | |
|---|---|---|
Market Cap | $73.56B | $26.52B |
Sector | Health | Technology |
52-Week High | $311.00 | $310.00 |
52-Week Low | $244.41 | $211.49 |
Enterprise Value | $98.27B | $27.82B |
Dividend Yield | 2.24% | 1.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
VRSN trades at $294.56, up 0.69% today, with a bullish technical signal and strong support near $290. The company reported Q2 2026 revenue of $435 million, up 6% year-over-year, with EPS of $2.38 beating expectations. Analyst consensus is a Buy with a $320 price target, citing growth from AI-driven domain registrations and the recent .web domain delegation.
Outlook remains positive with double-digit profit growth potential from pending price hikes, though risks include contract renewals and high valuation multiples. The stock's current price offers an 8.6% upside to the consensus target, supported by stable cash flows and a dominant market position in domain registry services.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →
